These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7838920)

  • 1. Savoxepine fails to selectively influence glucose metabolism in the rat limbic system.
    Cascella NG; Tarazi FI; Shirakawa O; Tamminga CA
    Psychopharmacology (Berl); 1994 Mar; 114(2):275-80. PubMed ID: 7838920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose raclopride spares the extrapyramidal system in rat brain from metabolic effects.
    Tarazi FI; Shirakawa O; Tamminga CA
    Eur J Pharmacol; 1993 Feb; 232(1):71-7. PubMed ID: 8096189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
    Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA
    Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Savoxepine versus haloperidol. Reasons for a failed controlled clinical trial in patients with an acute episode of schizophrenia.
    Volz HP; Möller HJ; Gerebtzoff A; Bischoff S
    Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):76-80. PubMed ID: 12111340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of effects of the kappa-opioid agonist CI-977 on cerebral glucose utilization in rat brain.
    Mackay KB; McCulloch J
    Brain Res; 1994 Apr; 642(1-2):160-8. PubMed ID: 8032876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists.
    Sharkey J; Ritchie IM; Butcher SP; Kelly JS
    Brain Res; 1996 Sep; 735(1):67-82. PubMed ID: 8905171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system.
    Bartholini G
    J Pharm Pharmacol; 1976 May; 28(5):429-33. PubMed ID: 6752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
    Broderick PA; Piercey MF
    J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limbic brain structures are important sites of kappa-opioid receptor-mediated actions in the rat: a [14C]-2-deoxyglucose study.
    Ableitner A; Herz A
    Brain Res; 1989 Jan; 478(2):326-36. PubMed ID: 2538203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of haloperidol on release of neurotensin in extrapyramidal and limbic systems.
    Huang W; Hanson GR
    Eur J Pharmacol; 1997 Jul; 332(1):15-21. PubMed ID: 9298921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of effects of haloperidol on energy metabolism in the rat brain.
    McCulloch J; Savaki HE; Sokoloff L
    Brain Res; 1982 Jul; 243(1):81-90. PubMed ID: 7116160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dopamine partial-agonist aminoergolines on dopamine metabolism in limbic and extrapyramidal regions of rat brain.
    Baldessarini RJ; Marsh ER; Huston-Lyons D
    Biochem Pharmacol; 1994 May; 47(10):1917-9. PubMed ID: 7911303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of amisulpride, an atypical antipsychotic which blocks preferentially presynaptic dopamine autoreceptors, on integrated functional cerebral activity in the rat.
    Cudennec A; Fage D; Bénavidès J; Scatton B
    Brain Res; 1997 Sep; 768(1-2):257-65. PubMed ID: 9369323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects.
    Bartlett EJ; Brodie JD; Simkowitz P; Dewey SL; Rusinek H; Wolf AP; Fowler JS; Volkow ND; Smith G; Wolkin A
    Am J Psychiatry; 1994 May; 151(5):681-6. PubMed ID: 8166309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain.
    Karolewicz B; Antkiewicz-Michaluk L; Michaluk J; Vetulani J
    Eur J Pharmacol; 1996 Oct; 313(3):181-6. PubMed ID: 8911913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine agonist action in mesolimbic, cortical and extrapyramidal areas to modify spontaneous climbing behaviour of the mouse.
    Costall B; Eniojukan JF; Naylor RJ
    Psychopharmacology (Berl); 1985; 86(4):452-7. PubMed ID: 3929317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective antidopaminergic effects of S(+)N-n-propylnoraporphines in limbic versus extrapyramidal sites in rat brain: comparisons with typical and atypical antipsychotic agents.
    Campbell A; Yeghiayan S; Baldessarini RJ; Neumeyer JL
    Psychopharmacology (Berl); 1991; 103(3):323-9. PubMed ID: 1676180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors.
    Fuxe K; Fredholm BB; Agnati LF; Corrodi H
    Brain Res; 1978 May; 146(2):295-311. PubMed ID: 647392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.